Literature DB >> 7682643

Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus.

K Nakanishi1, T Kobayashi, H Miyashita, M Okubo, T Sugimoto, T Murase, K Kosaka, M Hara.   

Abstract

Quantitative analysis was performed using computerized morphometry on the relationships between residual beta cells, pancreatic exocrine glands, and islet cell antibodies (ICA) in 14 pancreata of insulin-dependent diabetic (IDDM) patients. Both pancreatic exocrine glands and beta cells were markedly reduced in weight in IDDM patients compared with non-insulin-dependent diabetic (NIDDM) patients or nondiabetic controls. beta cells were preserved in six cases and were completely abolished in eight cases. In nine IDDM pancreata weighed at autopsy, the weights of pancreatic exocrine glands in six patients with either no or virtually no residual beta cells (32.3 +/- 1.6 g) were greater than those in three patients with residual beta cells (23.1 +/- 2.5 g, P < .05). Infiltration of lymphocytes positive for leukocyte common antigen (LCA) around the islet was observed in only one case with ICA and residual beta cells. Infiltration of LCA-positive lymphocytes around pancreatic acinar cells was observed in 50% (six of 12) of patients examined. The weight of pancreatic exocrine glands in patients with LCA-positive lymphocyte infiltration (26.2 +/- 2.3 g) was lower than that in patients without this condition (33.2 +/- 2.4 g, P < .05). Pancreatic cytokeratin autoantibodies (PKA) were detected in four of 10 patients examined. In addition, all four ICA-positive patients had residual beta cells, while only one of seven ICA-negative patients had residual beta cells (P = .03).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682643     DOI: 10.1016/0026-0495(93)90035-m

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

Review 1.  Latent autoimmune diabetes in adults (LADA).

Authors:  Ramachandra G Naik; Jerry P Palmer
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.

Authors:  Kazuyuki Ishida; Hiroshi Mitoma; Yoshiaki Wada; Teruaki Oka; Junji Shibahara; Yuko Saito; Shigeo Murayama; Hidehiro Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-21       Impact factor: 10.154

3.  Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes.

Authors:  Martha L Campbell-Thompson; Stephanie L Filipp; Joseph R Grajo; Bimota Nambam; Richard Beegle; Erik H Middlebrooks; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Michael J Haller
Journal:  Diabetes Care       Date:  2018-12-14       Impact factor: 19.112

4.  Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243.

Authors:  T Kobayashi; Y Oka; H Katagiri; A Falorni; A Kasuga; I Takei; K Nakanishi; T Murase; K Kosaka; A Lernmark
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 5.  Insulitis in human type 1 diabetes: The quest for an elusive lesion.

Authors:  Peter In't Veld
Journal:  Islets       Date:  2011-07-01       Impact factor: 2.694

6.  β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis.

Authors:  Carol J Lam; Daniel R Jacobson; Matthew M Rankin; Aaron R Cox; Jake A Kushner
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

Review 7.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

8.  Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.

Authors:  Shoichiro Tanaka; Yoriko Nishida; Kaoru Aida; Taro Maruyama; Akira Shimada; Masako Suzuki; Hiroki Shimura; Soichi Takizawa; Masashi Takahashi; Daiichiro Akiyama; Sayaka Arai-Yamashita; Fumihiko Furuya; Akio Kawaguchi; Masahiro Kaneshige; Ryohei Katoh; Toyoshi Endo; Tetsuro Kobayashi
Journal:  Diabetes       Date:  2009-07-29       Impact factor: 9.461

9.  Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice.

Authors:  Eric J Grossman; David D Lee; Jing Tao; Raphael A Wilson; Soo-Young Park; Graeme I Bell; Anita S Chong
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

10.  Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.

Authors:  Hao Yin; Soo-Young Park; Xiao-Jun Wang; Ryosuke Misawa; Eric J Grossman; Jing Tao; Rong Zhong; Piotr Witkowski; Graeme I Bell; Anita S Chong
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.